Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Carruthers

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
American Heart Journal|September 1, 1999
Assimilating new therapeutic interventions into clinical practice: how does hypertension compare with other therapeutic areas?S G Carruthers
Drug Safety|July 1, 1994
Adverse effects of alpha 1-adrenergic blocking drugsS G Carruthers
Advances in Experimental Medicine and Biology|March 20, 2002
The diabetic hypertensive (or hypertensive diabetic)--a compelling need to optimize blood pressureS G Carruthers
Arquivos Brasileiros De Cardiologia|March 1, 1984
Measurement of partial agonist activity in man and its therapeutic relevanceS G Carruthers
British Medical Journal|September 4, 1971
Persistent tardive dyskinesiaS G Carruthers
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1986
After Eastman: a boost for clinical research?S G Carruthers
Journal of Clinical Pharmacology|March 1, 1993
The place of alpha blockers in the antihypertensive armamentariumS G Carruthers
The Canadian Journal of Cardiology|July 1, 1992
The J-curve--it is clinically relevant?S G Carruthers
Clinical Pharmacology and Therapeutics|July 22, 2009
A truncated erythropoietin receptor EPOR-T is associated with hypertension susceptibilityS G Carruthers
Canadian Family Physician Medecin De Famille Canadien|February 1, 1993
Cardiovascular risk factors in perspectiveS G Carruthers
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
American Heart Journal|September 1, 1999
Assimilating new therapeutic interventions into clinical practice: how does hypertension compare with other therapeutic areas?S G Carruthers
Drug Safety|July 1, 1994
Adverse effects of alpha 1-adrenergic blocking drugsS G Carruthers
Advances in Experimental Medicine and Biology|March 20, 2002
The diabetic hypertensive (or hypertensive diabetic)--a compelling need to optimize blood pressureS G Carruthers
Arquivos Brasileiros De Cardiologia|March 1, 1984
Measurement of partial agonist activity in man and its therapeutic relevanceS G Carruthers
British Medical Journal|September 4, 1971
Persistent tardive dyskinesiaS G Carruthers
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1986
After Eastman: a boost for clinical research?S G Carruthers
Journal of Clinical Pharmacology|March 1, 1993
The place of alpha blockers in the antihypertensive armamentariumS G Carruthers
The Canadian Journal of Cardiology|July 1, 1992
The J-curve--it is clinically relevant?S G Carruthers
Clinical Pharmacology and Therapeutics|July 22, 2009
A truncated erythropoietin receptor EPOR-T is associated with hypertension susceptibilityS G Carruthers
Canadian Family Physician Medecin De Famille Canadien|February 1, 1993
Cardiovascular risk factors in perspectiveS G Carruthers
Pageof 12